Skip to Main Content

News Center

Pharmacy Practice

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

May 7, 2020

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

Federal Government Authorizes Pharmacists to Administer COVID-19 Tests

May 4, 2020

New guidance from the U.S. Department of Health and Human Services adds licensed pharmacists as “covered persons” under the Public Readiness and Emergency Preparedness (PREP) Act.

New Guide Helps Clinicians Optimize Medication Management During COVID-19 Pandemic

April 30, 2020

Guide published by the Peter Lamy Center on Drug Therapy and Aging and US Deprescribing Research Network offers recommendations to improve resident-centered health and reduce opportunities for transmission of COVID-19 in post-acute and long-term care facilities.

SOP’s ATRIUM Cardiology Collaborative Launches New Mobile App

February 26, 2020

Application available to download for Android and iOS offers guidance to health care professionals in selecting and dosing anticoagulant therapy for patients.

School of Pharmacy Mourns Passing of Retired Faculty Member, Alumnus

October 17, 2019

Robert Michocki, PharmD ’75, BCPS, is remembered for his 43 years of service as a teacher, role model, and mentor at the University of Maryland School of Pharmacy.

SOP Collaborates with emocha to Offer Comprehensive Clinical Adherence Solution

October 16, 2019

Leaders in technology and pharmacy collaborate to offer the first technology-enabled adherence solution to fight the country’s deadliest chronic diseases.

Pumas-AI Launches Pumas Software to Advance Drug Development, Patient Care

July 19, 2019

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.